Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1 Lupus Erythematosus, Systemic 1 Infections 1

Interventions

gamma-Globulins 3 Trimethoprim, Sulfamethoxazole Drug Combination 3 Rituximab 2 Immunoglobulins, Intravenous 2 Ciprofloxacin 2 Amoxicillin-Potassium Clavulanate Combination 2 plerixafor 1 anifrolumab 1 Wearable Electronic Devices 1 Tenofovir 1 Plastic Surgery Procedures 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Lenalidomide 1 Health Information Exchange 1 Bevacizumab 1 Antibiotic Prophylaxis 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Infections × anifrolumab × 1 year × Clear all

NCT07000110 2026-05-20

SIMA

AstraZeneca

Infections, Lupus Erythematosus, Systemic, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡